ArticleCureus2026
Late-Onset Metastatic Signet Ring Cell Adenocarcinoma Following Bladder Exstrophy Reconstruction: Diagnostic Discordance and Uncertain Primary Origin.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bladder exstrophy is an uncommon congenital anomaly associated with a heightened lifetime risk of malignancy, particularly following reconstructive procedures incorporating intestinal segments. We describe a 60-year-old man with a history of bladder exstrophy repair who presented with flank pain and microscopic haematuria. Initial imaging suggested a bladder lesion; however, histological examination revealed a villous adenoma without evidence of malignancy. Subsequent investigations identified extensive skeletal metastases. Biopsy of a bony lesion demonstrated metastatic adenocarcinoma with signet ring cell morphology. Immunohistochemical analysis showed positivity for CK20 and CDX2 and negativity for CK7, suggesting a gastrointestinal origin. Despite a comprehensive evaluation, no primary tumour was identified. Following a multidisciplinary team discussion, the patient was commenced on systemic chemotherapy and bone-targeted therapy for presumed colorectal carcinoma. This case highlights the diagnostic complexity associated with malignancy in reconstructed urinary tracts and emphasises the need for long-term surveillance in this patient population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.